Water intake in CKD improves or worsens disease? Study sheds light

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-04-20 04:40 GMT   |   Update On 2022-04-20 04:40 GMT

France: Relation between plain water intake and progresion to kidney failure is not linear but U-shaped in patients with chronic kidney disease (CKD), reveals a recent study. This implies that both low and high water intake may not be beneficial for CKD patients. The study appears in the journal Nephrology Dialysis Transplantation. Based on the study, the authors suggest, "an optimum range...

Login or Register to read the full article

France: Relation between plain water intake and progresion to kidney failure is not linear but U-shaped in patients with chronic kidney disease (CKD), reveals a recent study. This implies that both low and high water intake may not be beneficial for CKD patients. The study appears in the journal Nephrology Dialysis Transplantation. 

Based on the study, the authors suggest, "an optimum range of 1–2 L/day water intake for CKD patients that needs to be confirmed in other cohorts or clinical trials." "This range may be recommended, with adjustments to thrst and excretion until new guidelines have reviewed evidence about hydration tailored for CKD patients," they wrote. 

Not much is known about optimal daily water intake for preventing CKD progression. Considering this, Sandra Wagner, Université de Lorraine, Nancy, France, and colleagues aimed to the relation of kidney outcomes in patients with CKD to total and plain water intake and urine volume taking into account the kidney's urine-concentrating ability. 

For the purpose, the researchers included 1265 CKD patients [median age 69 years; mean estimated glomerular filtration rate (eGFR) 32 mL/min/1.73 m2] from the Chronic Kidney Disease–Renal Epidemiology and Information Network cohort (2013–19). They assessed fluid intake at baseline interviews, collected 24-h urine volumes and estimated urine osmolarity (eUosm). 

Hazard ratios (HRs) were estimated for kidney failure and eGFR decline associated with hydration markers using Cox and then linear mixed models after adjusting for CKD progression risk factors and eUosm. 

Based on the study, the researchers found the following:

  • Patients' median daily intake was 2.0 L for total water and 1.5 L for plain water, median urine volume was 1.9 L/24 h and mean eUosm was 374 ± 104 mosm/L.
  • Neither total water intake nor urine volume was associated with either kidney outcome.
  • Kidney failure risk increased significantly with decreasing eUosm ˂292 mosm/L.
  • Adjusted HRs for kidney failure associated with plain water intake were 1.88, 1.59, 1.76 and 1.55 in patients drinking <0.5, 0.5–1.0, 1.5–2.0 and >2.0 L/day compared with those drinking 1.0–1.5  L/day.
  • High plain water intake was also significantly associated with faster eGFR decline.

"These findings may have important clinical implications for CKD management," the authors concluded. "There is a need for further investigations in other cohorts and clinical trials to confirm the optimal level of water intake in CKD patients suggested by our results and define specific water recommendations tailored for non-dialysis CKD patients."

Reference:

Sandra Wagner, Thomas Merkling, Marie Metzger, Lise Bankir, Maurice Laville, Luc Frimat, Christian Combe, Christian Jacquelinet, Denis Fouque, Ziad A Massy, Bénédicte Stengel, for the CKD-REIN study group, Water intake and progression of chronic kidney disease: the CKD-REIN cohort study, Nephrology Dialysis Transplantation, Volume 37, Issue 4, April 2022, Pages 730–739, https://doi.org/10.1093/ndt/gfab036


Tags:    
Article Source : Nephrology Dialysis Transplantation

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News